ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,382Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 288

$595K Total Retail Price of All Prescriptions

Rank: 45 out of 288

465 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,704 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 643 560 1 2
SIMVASTATIN 603 532 2 1
FUROSEMIDE 573 545 3 5
OMEPRAZOLE 567 472 4 3
LISINOPRIL 552 480 5 4
AMLODIPINE BESYLATE 470 437 6 6
METOPROLOL TARTRATE 372 330 7 8
WARFARIN SODIUM 354 334 8 9
ALENDRONATE SODIUM 331 306 9 20
HYDROCHLOROTHIAZIDE 309 284 10 13
ATORVASTATIN CALCIUM 280 260 11 14
POTASSIUM CHLORIDE 257 229 12 11
ATENOLOL 232 232 13 10
HYDROCODONE-ACETAMINOPHEN 203 181 S3 14 7
METFORMIN HCL 200 181 15 12
PRAVASTATIN SODIUM 198 153 16 21
ALLOPURINOL 174 137 17 23
METOPROLOL SUCCINATE 171 139 18 15
CARVEDILOL 163 163 19 27
NAMENDA 145 145 20 39
CLOPIDOGREL 140 125 21 47
SERTRALINE HCL 139 131 22 25
LOSARTAN POTASSIUM 137 123 23 16
GABAPENTIN 133 117 24 17
GLIMEPIRIDE 110 93 25 32
OXYBUTYNIN CHLORIDE 106 87 26 69
ESCITALOPRAM OXALATE 100 92 27 87
TRAZODONE HCL 99 78 28 37
ZOLPIDEM TARTRATE 97 87 29 22
PLAVIX 93 89 30 71
DONEPEZIL HCL 93 93 30 29
PROPRANOLOL HCL 91 47 32 90
TRIAMTERENE-HCTZ 90 85 33 28
GLYBURIDE 88 74 R 34 59
CRESTOR 85 42 35 26
MIRTAZAPINE 84 79 36 60
CIPROFLOXACIN HCL 79 69 37 62
LIPITOR 79 63 37 107
ADVAIR DISKUS 77 67 39 50
CITALOPRAM HBR 77 76 39 18
LANTUS 75 65 41 31
FLUOXETINE HCL 74 53 42 64
SPIRONOLACTONE 71 67 43 36
NABUMETONE 70 57 44 108
LOVASTATIN 69 69 45 46
MELOXICAM 67 67 46 44
NIASPAN 67 40 46 103
POLYETHYLENE GLYCOL 3350 64 50 48 38
PAROXETINE HCL 64 63 48 54
DILTIAZEM ER 64 64 48 102
TAMSULOSIN HCL 64 56 48 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 59 52 34
RANITIDINE HCL 62 59 52 33
CYMBALTA 61 51 54 67
ISOSORBIDE MONONITRATE ER 61 61 54 35
FLUTICASONE PROPIONATE 60 40 56 41
NEXIUM 60 60 56 43
FENTANYL 58 58 S2 58 57
AMITRIPTYLINE HCL 56 53 R 59 65
PREDNISONE 55 41 60 30
JANTOVEN 52 49 61 146
BACLOFEN 51 31 62 121
FAMOTIDINE 51 47 62 68
ATENOLOL-CHLORTHALIDONE 50 29 64 188
LEVETIRACETAM 50 50 64 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.